Related Experiment Video
Updated: May 5, 2026

Breast Milk Enhances Growth of Enteroids: An Ex Vivo Model of Cell Proliferation
Published on: February 15, 2018
Effect of Probiotic Supplementation in Preventing Necrotizing Enterocolitis Sepsis and Mortality Among Preterm and
Hamdah T Kalantar1, Sara Galadari2, Ahmad Tariq Kalantar3
1Medicine and Surgery, Mohammed Bin Rashid University of Medicine and Health Sciences, Dubai, ARE.
Insights
Probiotic supplementation in preterm infants significantly reduces necrotizing enterocolitis (NEC) and improves feeding tolerance and hospital outcomes. Multi-strain probiotics show greater efficacy, though mortality remains unaffected.
Area of Science:
- Neonatalogy
- Microbiology
- Gastroenterology
Background:
- Preterm and VLBW infants possess immature gut barriers, dysbiosis, and underdeveloped immunity, increasing vulnerability to NEC and sepsis.
- Necrotizing enterocolitis (NEC) and late-onset sepsis are major contributors to morbidity and mortality in vulnerable infant populations.
- Probiotic supplementation is explored to restore gut microbial balance and enhance gastrointestinal maturation.
Purpose of the Study:
- To systematically review the impact of probiotics on NEC, sepsis, mortality, feeding tolerance, and hospitalization in preterm and VLBW infants.
- To evaluate clinical trends and strain-specific efficacy of probiotic interventions.
- To assess related physiological outcomes, including inflammatory and metabolic markers.
Main Methods:
- Systematic literature review adhering to PRISMA guidelines.
- Inclusion of studies examining probiotic interventions in preterm or VLBW populations.
- Narrative synthesis of extracted data on primary (NEC, sepsis, mortality) and secondary outcomes.
Main Results:
- Multi-strain probiotics consistently reduced NEC incidence and improved feeding tolerance, accelerating oral feeding and shortening hospitalization.
- Selected probiotics lowered C-reactive protein and total serum bilirubin, indicating systemic benefits.
- Single-strain probiotics showed variable efficacy, and mortality outcomes were consistently unaffected by probiotic interventions.
Conclusions:
- Probiotics are safe and offer clinically significant benefits for preterm and VLBW infants, especially in NEC prevention and improving feeding and hospital outcomes.
- Multi-strain probiotic formulations appear more effective than single-strain options.
- Strain selection is crucial for optimizing therapeutic outcomes in probiotic interventions for vulnerable infants.
Abstract:
Preterm and very low birth weight (VLBW) infants are highly vulnerable to gastrointestinal and systemic complications due to immature gut barriers, dysbiosis, and underdeveloped immunity, with necrotizing enterocolitis (NEC) and late-onset sepsis contributing significantly to morbidity and mortality. Probiotic supplementation has been proposed as a strategy to restore gut microbial balance, enhance gastrointestinal maturation, and reduce disease risk. This study systematically reviews the impact of probiotics on NEC, sepsis, mortality, feeding tolerance, hospitalization, and related physiological outcomes in preterm and VLBW infants. Studies were identified through databases in accordance with Preferred Reporting Items for Systematic reviews and Meta-Analyses (PRISMA) guidelines, including those that examined probiotic interventions in preterm or VLBW populations. Primary outcomes assessed were NEC, sepsis, and mortality, while secondary outcomes included feeding tolerance, hospital stay, and inflammatory or metabolic markers. Data were extracted and synthesized narratively to evaluate clinical trends and strain-specific efficacy. Findings showed that multi-strain probiotic supplementation consistently reduced NEC incidence, improved feeding tolerance, accelerated full oral feeding, and shortened hospitalization. Selected probiotics also lowered C-reactive protein and total serum bilirubin, suggesting systemic anti-inflammatory and metabolic benefits, whereas single-strain probiotics demonstrated variable efficacy. Mortality outcomes, however, were consistently unaffected across studies. Overall, probiotics are safe and provide clinically significant benefits in preterm and VLBW infants, particularly for NEC prevention and improved feeding and hospital outcomes, with multi-strain formulations appearing more effective and underscoring the importance of strain selection for optimizing therapeutic outcomes.
Related Concept Videos
Probiotics
Development of Human Microbiota
Development of the Oral Microbiota

